The CDKL5 gene gives instructions for a protein that helps brain cells grow, connect, and send signals, especially early in life. This gene plays an important role in healthy brain development. When a harmful variant disrupts the CDKL5 gene, it can cause CDKL5 deficiency disorder, a condition linked to early-onset seizures, major developmental delays, low muscle tone, and differences in movement, vision, or communication. Effects vary from person to person, but symptoms often begin in infancy.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you react to food, stress, or medicines. More detail on this topic is available in the LearnHub.
Overview
CDKL5Gene function
What if the gene works
The CDKL5 gene helps brain cells grow, connect, and send signals, especially early in development. Its protein supports normal nerve cell function.
Risk
What if the gene does not work
When the CDKL5 gene is not working properly, children often develop early onset seizures and major delays in movement, learning, and communication. Milder to more severe variants can affect when symptoms begin and how much abilities are impacted.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the CDKL5 gene can make ganaxolone a treatment option for seizures linked to CDKL5 deficiency disorder. Other seizure medicines may still be used, but response often varies from person to person. There is no approved treatment yet that corrects the underlying CDKL5 gene change.
Conditions associated with CDKL5
Gene function
What if the gene works
In brain cells, the CDKL5 gene helps cells grow, organize, and communicate during early development and daily activity. It makes a protein kinase, which is a protein that switches other proteins on or off by adding a small chemical tag. This gives a practical picture of the CDKL5 gene's function in brain cells as connections form and signals pass from one cell to the next.
The CDKL5 gene makes a kinase protein, a protein that adds a small chemical tag to other proteins. This tag helps control when certain cell tasks turn on, slow down, or change direction.
Inside developing nerve cells, the CDKL5 gene supports growth and maturation. It helps young neurons build their shape so they can take their place in brain networks.
This gene helps nerve cells form and maintain connections called synapses, where signals pass from one cell to another. That steady connection building supports everyday communication across brain circuits.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CDKL5 gene can change the shape, stability, or activity of the CDKL5 protein, often reducing how well it sends signals needed for brain cell development. Some variants partly lower protein function, while more disruptive variants can stop the protein from being made or leave it unable to work at all. This spectrum helps explain how CDKL5 gene variants affect protein function and why some people have earlier onset or more marked features than others.
How variants are linked to conditions
Conditions linked to the CDKL5 gene are centered on CDKL5 deficiency disorder, which usually starts in infancy with seizures and marked delays in development. Many children also have low muscle tone, limited speech, feeding problems, sleep difficulties, and movement or vision differences. This diagnosis can vary in severity, but a pathogenic variant in the CDKL5 gene can confirm it.
A variant is not necessarily a diagnosis
Human biology normally includes genetic variants, and they are widespread in the general population. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, particularly when several genes and environmental factors play a role. In contrast, some situations involve a single well-characterized variant in a specific gene that is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CDKL5, risk is driven mainly by whether a disease-causing change in the gene is present, and most cases happen as a new change rather than being passed down. Daily habits are not known to change the chance of having a CDKL5-related condition, although family history and, in some families, whether the change is inherited can affect recurrence risk.
Inheritance of CDKL5 variants
CDKL5-related conditions usually follow an X-linked dominant inheritance pattern. This means a parent with a pathogenic variant in the CDKL5 gene can pass it on to a child, with inheritance differing between sons and daughters because the CDKL5 gene is on the X chromosome. A mother carrying the variant can pass it to either sons or daughters, while a father carrying it would pass it to all daughters and no sons. In many families, the CDKL5 inheritance pattern starts with a new (de novo) variant in the child rather than one inherited from either parent.
What does my CDKL5 result mean for my family?
CDKL5-related conditions usually follow an X-linked pattern, so close relatives can sometimes carry the same gene change even if symptoms differ. Parents, brothers, sisters, and future children may have a chance of sharing it, so the result can matter beyond one person. Many CDKL5 changes happen for the first time in a child and are not inherited from either parent, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
CDKL5 genetic testing looks for variants in the CDKL5 gene using a blood or saliva sample. A lab reads the gene’s DNA code and may also check for missing or extra pieces, which can help confirm whether a condition linked to the CDKL5 gene explains seizures, developmental differences, or related symptoms.
When should I consider getting a genetic test?
Genetic testing for the CDKL5 gene may be worth considering when a baby or young child has seizures starting very early in life, along with major delays in development, low muscle tone, or limited eye contact. It can also be helpful when there is a known CDKL5 gene change in the family.
A genetic result is only one part of your health story
Genetic test results can offer useful insight, but how much they reveal varies by the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how your body works. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug works well for one person, has less effect in another, or causes more side effects in someone else. Small differences in genes can change how the body breaks down a medicine, moves it through the body, or responds to it at its target, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It looks at gene and drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed, more personalized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CDKL5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so general health or medication concerns are best discussed with your doctor. For CDKL5, research has looked at seizure treatment in people living with CDKL5-related epilepsy, but it has not led to standard gene-based prescribing advice.
History
The CDKL5 gene entered medical literature in the early 2000s, when researchers linked changes in this gene to infants with very early seizures and major developmental challenges. At first, some affected children were thought to have an unusual form of Rett syndrome because the early clinical features could look similar. Scientific classifications changed as researchers learned more about the gene. Over time, doctors recognized CDKL5 deficiency disorder as its own condition, separate from Rett syndrome, with a distinct pattern of early epilepsy and developmental differences. From these first observations, research expanded steadily. This shift helped families receive a clearer diagnosis and gave clinicians a more accurate way to describe the condition.